Rocket Doctor AI Inc. (AIRDF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $40.7M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRocket Doctor AI Inc. (AIRDF) trades at $0.42. Rocket Doctor AI Inc. provides personalized healthcare information services in Canada, utilizing a mobile application for symptom assessment and ongoing wellness management. Market cap: $40.7M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for AIRDF: AIRDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AIRDF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
AIRDF: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Rocket Doctor AI Inc. (AIRDF) Healthcare & Pipeline Overview
Rocket Doctor AI Inc., based in Canada, develops and offers a mobile application for personalized healthcare information and symptom assessment. The company provides digital health solutions and medical education resources, positioning itself within the competitive healthcare information services sector with a focus on mobile accessibility and user-centric design.
What Is the Investment Thesis for AIRDF?
Rocket Doctor AI Inc. presents an investment opportunity within the growing digital health information services sector. The company's focus on personalized healthcare through its mobile application and digital health tools aligns with the increasing demand for accessible and convenient healthcare solutions. With a market capitalization of $40.7M and a negative P/E ratio of -4.44, the company is currently operating at a loss, indicated by a profit margin of -1670.1%. However, the company's high gross margin of 89.4% suggests potential for profitability as it scales its operations. Key growth catalysts include expanding the user base of its mobile application and developing new digital health solutions. Investors should monitor the company's ability to achieve profitability and manage its operational costs effectively. The company's beta of -0.32 indicates low volatility compared to the market.
Based on FMP financials and quantitative analysis
AIRDF Key Highlights
Market capitalization of $40.7M indicates a small-cap company with potential for growth.
- Negative P/E ratio of -4.44 reflects current losses, but also potential for future earnings growth.
- Gross margin of 89.4% demonstrates strong pricing power and efficient cost management.
- Profit margin of -1670.1% highlights significant operational losses requiring strategic improvement.
- Beta of -0.32 suggests the stock is less volatile than the overall market.
Who Are AIRDF's Competitors?
AIRDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BLOZF Cannabix Technologies Inc. | $0.31 | +0.48% | $38.1M | — |
| HBPCF Helix BioPharma Corp. | $1.71 | 0.00% | $131M | — |
| INNMF Amplia Therapeutics Limited | $0.09 | -10.00% | $46.2M | — |
| ONMD OneMedNet Corporation | $0.67 | -1.84% | $38.0M | — |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
| CCLD CareCloud, Inc. | $2.04 | -3.32% | $86.7M | 725-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AIRDF's Key Strengths?
Proprietary mobile application for symptom assessment.
- Focus on personalized healthcare information.
- Partnerships with healthcare providers.
- High gross margin of 89.4%.
What Are AIRDF's Weaknesses?
Negative P/E ratio and profit margin indicate current losses.
- Limited geographic presence in Canada.
- Small market capitalization of $40.7M.
- Reliance on mobile application for revenue generation.
What Could Drive AIRDF Stock Higher?
Expansion of mobile application user base through targeted marketing campaigns.
- Development of new digital health solutions to address unmet needs in the market.
- Partnerships with healthcare providers to integrate its solutions into their existing workflows.
- Geographic expansion to other countries with similar healthcare needs.
- Integration of AI and machine learning into its platform to enhance its capabilities.
What Are the Key Risks for AIRDF?
Financial-distress signal — its Altman Z-Score of -12.23 sits in the distress zone (elevated bankruptcy risk).
- Competition from established healthcare information service providers with greater resources.
- Regulatory changes in the healthcare industry that could impact the company's operations.
- Data privacy and security concerns related to the collection and storage of patient data.
- Technological obsolescence due to rapid advancements in digital health technologies.
- Limited financial disclosure and liquidity associated with trading on the OTC Other tier.
What Are the Growth Opportunities for AIRDF?
- Expansion of Mobile Application User Base: Rocket Doctor AI Inc. can grow by expanding the user base of its mobile application. The global mobile health market is projected to reach $332.5 billion by 2028, growing at a CAGR of 17.9%. By focusing on user acquisition through targeted marketing and partnerships with healthcare providers, Rocket Doctor AI Inc. can increase its market share and revenue. Timeline: Ongoing.
- Development of New Digital Health Solutions: The company can develop new digital health solutions to address unmet needs in the market. The digital health market is expected to reach $660 billion by 2027. By investing in research and development, Rocket Doctor AI Inc. can create innovative products and services that attract new customers and generate additional revenue streams. Timeline: Ongoing.
- Partnerships with Healthcare Providers: Rocket Doctor AI Inc. can partner with healthcare providers to integrate its solutions into their existing workflows. The healthcare IT market is projected to reach $390.7 billion by 2027. By collaborating with hospitals, clinics, and other healthcare organizations, Rocket Doctor AI Inc. can expand its reach and improve patient outcomes. Timeline: Ongoing.
- Geographic Expansion: The company can expand its operations beyond Canada to other countries with similar healthcare needs. By entering new markets, Rocket Doctor AI Inc. can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Within the next 3-5 years.
- Integration of AI and Machine Learning: Rocket Doctor AI Inc. can further integrate AI and machine learning into its platform to enhance its capabilities. The AI in healthcare market is projected to reach $45.2 billion by 2026. By leveraging AI, the company can improve the accuracy of its symptom assessments, personalize its recommendations, and automate its processes. Timeline: Ongoing.
What Are AIRDF's Competitive Advantages?
- Proprietary AI-driven symptom assessment technology.
- Established partnerships with healthcare providers.
- First-mover advantage in the Canadian market for personalized healthcare information services.
What Does AIRDF Do?
Rocket Doctor AI Inc., formerly known as Treatment.com AI Inc., was incorporated in 2018 and is headquartered in Vancouver, Canada. The company focuses on delivering personalized healthcare information services through its mobile application. This application allows users to assess their symptoms, address health concerns, and manage their wellness. The company also offers a digital health app that provides insights into health management. Rocket Doctor AI Inc. provides medical education, medical clinic, and clinical advisor solutions, enhancing its service offerings. The company aims to provide accessible and personalized healthcare information resources to its users. The company rebranded in August 2025 to reflect its focus on AI-driven healthcare solutions. Rocket Doctor AI Inc. operates primarily in Canada, focusing on expanding its digital health services and mobile application reach within the region. The company's business model centers around providing accessible and personalized healthcare information through digital platforms.
What Products and Services Does AIRDF Offer?
- Develops a mobile application for symptom assessment.
- Offers personalized healthcare information services.
- Provides a digital health app for health insights.
- Offers medical education solutions.
- Provides medical clinic solutions.
- Provides clinical advisor solutions.
- Offers healthcare information resources.
How Does AIRDF Make Money?
- Generates revenue through subscriptions to its digital health app.
- Partnerships with healthcare providers for integration of its solutions.
- Offers medical education and clinical advisor solutions on a fee-for-service basis.
What Industry Does AIRDF Operate In?
Rocket Doctor AI Inc. operates in the healthcare information services sector, which is experiencing significant growth due to increasing demand for digital health solutions and personalized healthcare. The market is competitive, with players like BLOZF (BioLife Sciences Inc.), CRRVF (CareRx Corporation), DSOL (Data Solutions Holdings, Inc.), HBPCF (HBP Corp), and INNMF (InnoMedica Holdings AG). These companies offer various digital health services, including telehealth, remote patient monitoring, and healthcare data analytics. Rocket Doctor AI Inc. differentiates itself through its focus on AI-driven symptom assessment and personalized healthcare information delivered via its mobile application. The industry is driven by technological advancements, regulatory changes, and increasing healthcare costs, creating opportunities for innovative companies like Rocket Doctor AI Inc.
Who Are AIRDF's Key Customers?
- Individual users seeking personalized healthcare information.
- Healthcare providers looking to integrate digital health solutions.
- Medical professionals seeking medical education resources.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in CAD, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 56 |
| 2026-08-26 | 56 |
| 2026-08-29 | 56 |
| 2026-09-01 | 56 |
| 2026-09-04 | 56 |
| 2026-09-07 | 56 |
| 2026-09-10 | 56 |
What changed?
The score has stayed at 56.
Over the same 18 days the stock moved -4.8%.
Financial Health
Rocket Doctor AI Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -12.23 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -38.2%, showing how much profit it generates from its asset base. Its free cash flow yield is -5.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.09 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -17.4%, the inverse of the P/E and a quick read on earnings relative to price.
Rocket Doctor AI Inc. (AIRDF) Valuation Context
Valued at $40.7M, AIRDF is classified as a micro-cap stock.
AIRDF Revenue & Earnings Trend
In Q2 FY2026, AIRDF generated $512K in top-line revenue, marking a sequential decrease of 3.8%. The company recorded a net loss of $4.7M, with diluted EPS of $-0.05. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, AIRDF averaged $-0.05 in diluted EPS.
Company Profile
Rocket Doctor AI Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Essam Hamza. AIRDF has traded publicly since 2025.
AIRDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Proprietary mobile application for symptom assessment.
- Focus on personalized healthcare information.
- Partnerships with healthcare providers.
- High gross margin of 89.4%.
Bear Case
- Negative P/E ratio and profit margin indicate current losses.
- Limited geographic presence in Canada.
- Small market capitalization of $40.7M.
- Reliance on mobile application for revenue generation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $512,421.801 | -$5M | -$0.05 |
| Q1 FY2026 | $532,883.168 | -$3M | -$0.04 |
| Q4 FY2025 | $502,426.912 | -$5M | -$0.06 |
| Q3 FY2025 | $381,540.013 | -$3M | -$0.03 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Converted to USD from CAD at today's rate
AIRDF Latest News
-
Rocket Doctor AI Announces Global Company Town Hall to Showcase Q2 2026 Milestones and Strategic Vision
globenewswire.com · Sep 9, 2026
-
Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach
globenewswire.com · Sep 1, 2026
-
Rocket Doctor Grants Equity
globenewswire.com · Aug 24, 2026
-
Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels
globenewswire.com · Aug 18, 2026
AIRDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AIRDF.
Price Targets
Wall Street price target analysis for AIRDF.
AIRDF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AIRDF; grades run from A+ (80-100) to F (below 30).
Latest News
Rocket Doctor AI Announces Global Company Town Hall to Showcase Q2 2026 Milestones and Strategic Vision
Rocket Doctor AI Reports Strong Operational Momentum in Q2 2026 Driven by U.S. Expansion and Growing Patient Reach
Rocket Doctor Grants Equity
Rocket Doctor Enters New Strategic Network Agreement in California to Expand Access Across Multiple U.S. Healthcare Channels
Leadership: Essam Hamza
CEO
Essam Hamza is the CEO of Rocket Doctor AI Inc. His background includes experience in healthcare technology and business development. He has a track record of leading technology companies and driving innovation in the healthcare sector. His expertise lies in developing and implementing digital health solutions that improve patient outcomes and reduce healthcare costs. He is committed to expanding Rocket Doctor AI Inc.'s reach and impact in the healthcare industry.
Track Record: Under Essam Hamza's leadership, Rocket Doctor AI Inc. has focused on developing its mobile application and expanding its partnerships with healthcare providers. He has overseen the company's rebranding efforts and its transition to an AI-driven healthcare solutions provider. His strategic decisions have positioned the company for growth in the digital health market.
AIRDF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rocket Doctor AI Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in AIRDF.
- Lower liquidity can make it difficult to buy or sell shares at desired prices.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price manipulation and fraud.
- Higher volatility due to limited trading activity.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company's focus on AI-driven healthcare solutions.
- Partnerships with healthcare providers.
- Development of a mobile application for symptom assessment.
- Presence of a CEO with experience in healthcare technology.
- Company's headquarters in Vancouver, Canada.
AIRDF Healthcare Stock FAQ
Is AIRDF a good stock?
Stock Expert AI does not rate AIRDF buy, sell or hold. Rocket Doctor AI Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Rocket Doctor AI Inc. do?
Rocket Doctor AI Inc. is a Canadian company that provides personalized healthcare information services. It develops and offers a mobile application that allows users to assess their symptoms, address health concerns, and manage their wellness.
What do analysts say about AIRDF stock?
As of March 17, 2026, there is no available analyst coverage or consensus for Rocket Doctor AI Inc. (AIRDF) due to its OTC listing and small market capitalization.
What are the key factors to evaluate for AIRDF?
Evaluate AIRDF on fundamentals, analyst consensus, and risk factors. Rocket Doctor AI Inc. presents an investment opportunity within the growing digital health information services sector. Not financial advice.
How frequently does AIRDF data refresh on this page?
AIRDF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven AIRDF's recent stock price performance?
Rocket Doctor AI Inc. (AIRDF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary mobile application for symptom assessment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AIRDF overvalued or undervalued right now?
Rocket Doctor AI Inc. (AIRDF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of AIRDF?
Yes, most major brokerages offer fractional shares of Rocket Doctor AI Inc. (AIRDF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general knowledge of OTC markets and may not reflect specific details of AIRDF.
- AI insight is pending and not included in this analysis.